A JURISPRUDENTIAL REVIEW OF THE DRUGS AND COSMETICS ACT: BALANCING INNOVATION AND SAFETY IN THE INDIAN AESTHETIC SECTOR.

Abstract
Abstract: Legal and Regulatory Framework of Cosmetology in India (2026)
The cosmetology sector in India has transitioned from an unregulated grooming industry into
a high-precision medical and retail powerhouse, necessitating a robust legal framework. As of
2026, this framework is primarily anchored by the Drugs and Cosmetics Act, 1940, and the
Cosmetics Rules, 2020, as significantly updated by the 2025 Amendments. These regulations
mandate that all cosmetic products—whether manufactured locally or imported—undergo
rigorous registration through the Central Drugs Standard Control Organization (CDSCO)
via the digital SUGAM portal.
A critical shift in 2026 is the mandatory alignment with Bureau of Indian Standards (BIS)
quality control orders for high-risk categories like sunscreens and hair dyes, alongside refined
labeling requirements that distinguish between "Use Before" and "Date of Expiry" to enhance
consumer safety. Clinically, the landscape is governed by the National Medical Commission
(NMC) and the Clinical Establishments Act, which restrict advanced aesthetic procedures
(e.g., lasers, chemical peels) to qualified dermatologists and plastic surgeons. Furthermore, the
Medical Devices Rules, 2017, now classify energy-based devices, such as laser hair removal
machines, as regulated medical devices requiring specific CDSCO import or manufacturing
licenses (Form MD-14/42).
The regulatory environment also emphasizes post-market surveillance. The Consumer
Protection Act, 2019, works in tandem with the Drugs and Cosmetics Act to allow consumer
Page | 4
ISSN: 2581-8503
www.whiteblacklegal.co.in
Volume 3 Issue 6 | April 2026
associations to independently test products, holding brands accountable for "misbranded" or
"spurious" claims. Environmental compliance, specifically Biomedical Waste Management
Rules, has become a non-negotiable prerequisite for clinic licensing. This abstract concludes
that while the 2026 framework promotes industry growth and global export competitiveness, it
imposes stringent transparency, documentation, and qualification standards to mitigate the
health risks associated with the booming "medical aesthetics" market.
Key words:
Post-Market Surveillance; Misbranded and Spurious Cosmetics: Clinical Establishments
Act: Medical Devices Rules (MDR): Biomedical Waste Management: